Central retinal artery occlusion: Difference between revisions

No edit summary
 
(54 intermediate revisions by 9 users not shown)
Line 1: Line 1:
==Background==
==Background==
[[File:Schematic diagram of the human eye en.png|thumb|Eye anatomy.]]
*Abbreviation: CRAO
*The first branch of internal carotid artery is the ophthalmic artery
*More common in the elderly with carotid artery disease
*Restoration of blood flow within 100min may lead to complete recovery
**Occlusion >240min leads to irreversible damage
*5-10% of CRAO is associated with giant cell arteritis<ref>Miller N, Newman N. Walsh & Hoyt’s Clinical Neuro-ophthalmology. 5th Edition. Baltimore: Williams and Wilkins 1998. pp. 3758-9.</ref>
===Etiology===
===Etiology===
#Retinal Embolism (20%)
*[[thromboembolism|Embolism]]
#Atherosclerotic changes
*Thrombosis
#Angiospasm
*[[Temporal Arteritis]]
#Inflammatory Endarteritis
*[[Vasculitis]]
 
*[[Sickle Cell Disease]]
==Epidemiology==
*[[Blunt orbital trauma|Trauma]]
#Bilateral 1-2%
*Vasospasm ([[migraine]])  
#M>F
*[[Acute_Angle-Closure_Glaucoma|Glaucoma]]
 
*Low retinal blood flow ([[carotid stenosis]] or [[hypotension]])
==Symptoms==
Painless, monocular loss of vision
 
==DDx==
#Amaurosis fugax (painless, fleeting; nl exam)
#CRVO (painless, over hours; blood and thunder)
#Temporal Arteritis
#Acute glaucoma (blurry vision, eye pain)
 
==Exam==
 
Pale retina with edema
 
Cherry red spot at the macula
 
APD
 
Boxcar segmentation of blood column
 
 
==W/U==
 
 
Fundoscopic exam
 
CBC, ESR, EKG
 
 
==Treatment==
 
 
1. Ocular massage
 
2. Anterior chamber paracentesis
 
3. Intraarterial fibrinolysis
 
4. Acetazolamide
 
5. Mannitol
 
6. Timolol
 
7. Steroids
 
8. Hyperbarics (most effective if within 2-12h of presentation)
 


==Dispo==
==Clinical Features==
*Sudden, [[Acute vision loss (noninflamed)|painless, monocular vision loss]]
**Often preceded by episodes of [[amaurosis fugax]]
*APD


===[[Fundoscopy]]===
[[File:CRAO.png|thumb|Typical central retinal artery occlusion with cherry-red spot, retinal edema and narrowing of the vessels.]]
*Pale retina, cherry red macula
*Boxcar segmentation of blood column
*Cherry red spot
**Macula is thinnest portion of retina
**Intact underlying choroidal circulation remains visible through this section
***Macular area maintains normal color (red) versus surrounding ischemic, pale retina due to differing blood supplies


Admit: comorbid disease
==Differential Diagnosis==
{{Acute vision loss noninflamed DDX}}


D/C: f/u with ophtho in 1-4 weeks
==Evaluation==
*Etiology work-up
**ESR and CRP
**Carotid [[ultrasound|US]]
**[[ECG]]
**[[Echocardiography]] for embolus or atrial shunt
**CBC, coags, ANA, syphilis


   
==Management==
*Consult ophtho with goals for reducing [[intraocular pressure]], dislodging the embolus or increasing arterial flow


==Source==
*Start high dose systemic [[corticosteroids]] if high ESR/CRP (especially high CRP) and sudden vision loss
**Median starting PO [[prednisone]] 80mg/day, with 40% of patients on > 100mg/day
**Treat until BOTH ESR and CRP stabilize (~2-3 wks)<ref>Hayreh SS. Anterior Ischemic Optic Neuropathy. [Internet]. 2013 Available from: http://www.medicine.uiowa.edu/eye/AION-part2/.</ref>


No evidence supporting or refuting the following treatments: <ref>Rudkin A et al. Clinical characteristics and outcome of current standard management of central retinal artery occlusion. Clin Experiment Ophthalmol 2010; 38:496-501</ref>
*Ocular massage
**Intermittent direct digital pressure applied through closed eyelid x 10-15 sec with rapid release to create pressure gradient to dislodge embolism
*[[Timolol]] ophthalmic 0.5% to decrease intraocular pressure
**Alternative [[acetazolamide]] 500mg IV or PO<ref>Gerstenblith BI, Fecarotta CM. The Wills Eye Manual. Lippincott 2012.</ref>
*Increase PCO2 leading to retinal artery vasodilation/increased retinal blood flow 
**Rebreathe into paper bag x10 min q hr
**Inhale 95% O2 and 5% CO2 (Carbogen)<ref>Atebara N. Efficacy of anterior chamber paracentesis and carbogen in treating nonarteritic central retinal artery occlusion. Ophthalmology 1995; 102:2029-2038</ref>
*Anterior chamber paracentesis
**Causes acute drop in IOP to dislodge embolism
*Intraarterial fibrinolysis or low dose systemic [[thrombolytics]]<ref>Schumacher M, et al: Central retinal artery occlusion: Local intraarterial fibrinolysis versus conservative treatment, a multicenter
randomized trial. Ophthalmology 2010; 117:1367-1375</ref><ref>Chen C et al: Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: Report from a randomized, controlled trial. Stroke 2011; 42:2229-2234.</ref>
*[[Acetazolamide]], 500mg IV or PO
*[[Mannitol]]


H-N
==Disposition==
*Immediate ophthalmology consult


==See Also==


*[[Acute vision loss (noninflamed)]]


==References==
<references/>


[[Category:Ophtho]]
[[Category:Ophthalmology]]
[[Category:Vascular]]

Latest revision as of 20:57, 16 December 2020

Background

Eye anatomy.
  • Abbreviation: CRAO
  • The first branch of internal carotid artery is the ophthalmic artery
  • More common in the elderly with carotid artery disease
  • Restoration of blood flow within 100min may lead to complete recovery
    • Occlusion >240min leads to irreversible damage
  • 5-10% of CRAO is associated with giant cell arteritis[1]

Etiology

Clinical Features

Fundoscopy

Typical central retinal artery occlusion with cherry-red spot, retinal edema and narrowing of the vessels.
  • Pale retina, cherry red macula
  • Boxcar segmentation of blood column
  • Cherry red spot
    • Macula is thinnest portion of retina
    • Intact underlying choroidal circulation remains visible through this section
      • Macular area maintains normal color (red) versus surrounding ischemic, pale retina due to differing blood supplies

Differential Diagnosis

Acute Vision Loss (Noninflamed)

Emergent Diagnosis

Evaluation

  • Etiology work-up

Management

  • Consult ophtho with goals for reducing intraocular pressure, dislodging the embolus or increasing arterial flow
  • Start high dose systemic corticosteroids if high ESR/CRP (especially high CRP) and sudden vision loss
    • Median starting PO prednisone 80mg/day, with 40% of patients on > 100mg/day
    • Treat until BOTH ESR and CRP stabilize (~2-3 wks)[2]

No evidence supporting or refuting the following treatments: [3]

  • Ocular massage
    • Intermittent direct digital pressure applied through closed eyelid x 10-15 sec with rapid release to create pressure gradient to dislodge embolism
  • Timolol ophthalmic 0.5% to decrease intraocular pressure
  • Increase PCO2 leading to retinal artery vasodilation/increased retinal blood flow
    • Rebreathe into paper bag x10 min q hr
    • Inhale 95% O2 and 5% CO2 (Carbogen)[5]
  • Anterior chamber paracentesis
    • Causes acute drop in IOP to dislodge embolism
  • Intraarterial fibrinolysis or low dose systemic thrombolytics[6][7]
  • Acetazolamide, 500mg IV or PO
  • Mannitol

Disposition

  • Immediate ophthalmology consult

See Also

References

  1. Miller N, Newman N. Walsh & Hoyt’s Clinical Neuro-ophthalmology. 5th Edition. Baltimore: Williams and Wilkins 1998. pp. 3758-9.
  2. Hayreh SS. Anterior Ischemic Optic Neuropathy. [Internet]. 2013 Available from: http://www.medicine.uiowa.edu/eye/AION-part2/.
  3. Rudkin A et al. Clinical characteristics and outcome of current standard management of central retinal artery occlusion. Clin Experiment Ophthalmol 2010; 38:496-501
  4. Gerstenblith BI, Fecarotta CM. The Wills Eye Manual. Lippincott 2012.
  5. Atebara N. Efficacy of anterior chamber paracentesis and carbogen in treating nonarteritic central retinal artery occlusion. Ophthalmology 1995; 102:2029-2038
  6. Schumacher M, et al: Central retinal artery occlusion: Local intraarterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 2010; 117:1367-1375
  7. Chen C et al: Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: Report from a randomized, controlled trial. Stroke 2011; 42:2229-2234.